Lysogene SA Financials

We recommend to make use of Lysogene SA fundamental analysis to find out if markets are presently mispricing the entity. Strictly speaking this technique allows you to check out available financial ratios of Lysogene SA as well as the relationship between them. We were able to analyze and collect data for twenty-four available fundamentals for Lysogene, which can be compared to its peers in the industry. To ensure the equity is not overpriced, please verify all Lysogene SA financials, including its net income, as well as the relationship between the debt to equity and beta .
With this module, you can analyze Lysogene financials for your investing period. You should be able to track the changes in Lysogene individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  
Understanding current and past Lysogene Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Lysogene's financial statements are interrelated, with each one affecting the others. For example, an increase in Lysogene's assets may result in an increase in income on the income statement.
Evaluating Lysogene's financials involves analyzing a range of financial metrics and ratios to gain insights into the company's financial health and performance. However, considering all of Lysogene's profitability, liquidity ratios, and efficiency indicators at the same time could be an enormous task, and our Financial Distress score can provide you with a snapshot of the Lysogene's relative financial performance

Chance Of Distress

Over 100

 
100  
 
Zero
Dangerous
Lysogene SA has more than 100 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Lysogene pink sheet is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity.
Please note, Lysogene's odds of distress score SHOULD NOT be confused with the real chance of Lysogene SA filing for bankruptcy protection for chapters 7, 11, 12, or 13. We define Financial Distress as an operational condition where an entity such as Lysogene is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from public financial statements and analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors considered include Lysogene's liquidity analysis, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
More Info
The data published in Lysogene's official financial statements usually reflect Lysogene's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Lysogene SA. For example, before you start analyzing numbers published by Lysogene accountants, it's critical to develop an understanding of what Lysogene's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Lysogene's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Lysogene's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Lysogene's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Lysogene SA. Please utilize our Beneish M Score to check the likelihood of Lysogene's management manipulating its earnings.

Lysogene Company Summary

Lysogene competes with Nextplat Corp, Hibbett Sports, Duluth Holdings, Carters, and Boot Barn. Lysogene S.A. engages in the research and clinical development of gene therapy for neurodegenerative disorders. Lysogene S.A. was founded in 2009 and is based in Neuilly-sur-Seine, France. Lysogene operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 22 people.
InstrumentUSA Pink Sheet View All
ExchangePINK Exchange
Business Address18-20 rue Jacques
SectorHealthcare
IndustryBiotechnology
BenchmarkNYSE Composite
Websitewww.lysogene.com
Phone33 1 41 43 03 90
CurrencyUSD - US Dollar
You should never invest in Lysogene without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Lysogene Pink Sheet, because this is throwing your money away. Analyzing the key information contained in Lysogene's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Lysogene Key Financial Ratios

Generally speaking, Lysogene's financial ratios allow both analysts and investors to convert raw data from Lysogene's financial statements into concise, actionable information that can be used to evaluate the performance of Lysogene over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Lysogene SA reports annually and quarterly.

Lysogene Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Lysogene's current stock value. Our valuation model uses many indicators to compare Lysogene value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Lysogene competition to find correlations between indicators driving Lysogene's intrinsic value. More Info.
Lysogene SA is currently regarded as number one stock in gross profit category among related companies. It is currently regarded as number one stock in shares owned by insiders category among related companies . The ratio of Gross Profit to Shares Owned By Insiders for Lysogene SA is about  943,775 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Lysogene by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Lysogene's Pink Sheet . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Lysogene's earnings, one of the primary drivers of an investment's value.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the Lysogene SA information on this page should be used as a complementary analysis to other Lysogene's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Consideration for investing in Lysogene Pink Sheet

If you are still planning to invest in Lysogene SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Lysogene's history and understand the potential risks before investing.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments